gadobutrol
NDC 70710-2065, gadobutrol, injection, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-2065
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219287
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GADOBUTROL604.72 mg/mL
Pharmacologic classes
Gadolinium-based Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-2065-6 | 70710206506 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70710-2065-6) / 10 mL in 1 VIAL, SINGLE-DOSE (70710-2065-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/4ea8ae43-22ca-40c0-be72-c91a321cafd1
Use it
Look up 70710-2065 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-2065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.